|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 417/14 | |
| C07D 305/06 | |||
| C07D 305/08 |
| (11) | Number of the document | 3097098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15700600.8 |
| Date of filing the European patent application | 2015-01-21 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/051066 |
| Date | 2015-01-21 |
| (87) | Number | WO 2015/110446 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| PCT/CN2014/0713 | 2014-01-24 | WO |
| (72) |
CHEN, Junli, CN
REN, Yi, CN
SHE, Jin, CN
WANG, Lin, CN
YU, Jianhua, CN
ZHANG, Guocai, CN
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE |
| PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE |